Indonesia's Kalbe Farma moves into clinical testing

Pharmaceutical giant taps Japanese partners for technology

20180118_kalbe

Kalbe Farma's KALGen Innolab clinical laboratory in Jakarta

WATARU SUZUKI, Nikkei staff writer

JAKARTA -- Indonesian pharmaceutical company Kalbe Farma is entering the clinical testing business with two Japanese companies to tap the country's growing demand for prevention of lifestyle-related diseases.

Sponsored Content

About Sponsored ContentThis content was commissioned by Nikkei's Global Business Bureau.